BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3530788)

  • 1. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
    Hoepffner W; Hubl W
    Exp Clin Endocrinol; 1986 Jul; 87(2):189-94. PubMed ID: 3530788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
    Hubl W; Fehér T; Rohde W; Dörner G; Taubert H; Freymann E
    Endokrinologie; 1982 Jun; 79(2):165-72. PubMed ID: 6751805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J; Fiet J; Gourmelen M; Pham-Huu-Trung MT; Raux-Eurin MC; Brerault JL; Gueux B; Villette JM
    Ann Biol Clin (Paris); 1985; 43(4):333-7. PubMed ID: 4091295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: reference ranges throughout childhood and adolescence.
    Dressendorfer RA; Strasburger CJ; Bidlingmaier F; Klug I; Kistner A; Siebler T; Kiess W
    Pediatr Res; 1998 Nov; 44(5):650-5. PubMed ID: 9803445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 170H-progesterone rhythms in congenital adrenal hyperplasia.
    Young MC; Robinson JA; Read GF; Riad-Fahmy D; Hughes IA
    Arch Dis Child; 1988 Jun; 63(6):617-23. PubMed ID: 3389891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enzyme immunoassay for 17-hydroxyprogesterone in serum and saliva and from blood microfilter paper and microtitration plates].
    Füssel M; Hubl W; Weber S; Ilchmann D; Neef B; Hoepffner W
    Z Med Lab Diagn; 1988; 29(3):152-8. PubMed ID: 3043958
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 17-hydroxyprogesterone and other steroid hormones in saliva from a normal child and patients with congenital adrenal hyperplasia by plasmaspray liquid chromatography/mass spectrometry.
    Shindo N; Yamauchi N; Murayama K; Fairbrother A; Korlik S
    Biomed Chromatogr; 1990 Jul; 4(4):171-4. PubMed ID: 2207381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal 11-ketotestosterone and 17-hydroxyprogesterone saliva profiles in paediatric classical congenital adrenal hyperplasia.
    Dubinski I; Bechtold-Dalla Pozza S; Bidlingmaier M; Hawley J; Keevil B; Kunz S; Nowotny HF; Reisch N; Schiergens K; Tschaidse L; Schmidt H
    J Pediatr Endocrinol Metab; 2024 May; 37(5):419-424. PubMed ID: 38557593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of salivary 17-hydroxyprogesterone and its clinical usefulness in the study of hirsutism and the partial deficiency of 21-hydroxylase].
    Bonnín MR; Machuca I; Villabona C; González A; Soler J; Navarro MA
    Med Clin (Barc); 1994 Feb; 102(5):169-71. PubMed ID: 8127165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.
    Strott CA; Yoshimi T; Lipsett MB
    J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical assessment of the role of circadian rhythm of hormone contents in the blood and saliva of children with congenital dysfunction of the adrenal cortex].
    Fofanova OV
    Pediatriia; 1989; (11):38-41. PubMed ID: 2608371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
    Zerah M; Pang SY; New MI
    J Clin Endocrinol Metab; 1987 Aug; 65(2):227-32. PubMed ID: 3496350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Andrenogenital syndrome (author's transl)].
    Nieschlag E; Wenner H; Breu H; Wickings EJ; Schellong G
    Dtsch Med Wochenschr; 1980 Apr; 105(17):600-3. PubMed ID: 7371512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
    Adriaansen BPH; Kamphuis JS; Schröder MAM; Olthaar AJ; Bock C; Brandt A; Stikkelbroeck NMML; Lentjes EGWM; Span PN; Sweep FCGJ; Claahsen-van der Grinten HL; van Herwaarden AE
    Clin Endocrinol (Oxf); 2022 Jul; 97(1):36-42. PubMed ID: 35150157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.